ELDN Operating Cash Flow Growth
Eledon Pharmaceuticals Inc · Operating Cash Flow Growth
ELDN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-14.46%period ending
ELDN TTM Cash from Operations YoY % (-65.17% → -14.46%)
Year-over-year change
High-resolution chart · PNG
ELDN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -14.4555% | |
| -26.2008% | |
| -31.88% | |
| -79.706% | |
| -70.2747% | |
| -42.3691% | |
| -19.5917% | |
| 6.1716% | |
| -17.7072% | |
| -27.0005% | |
| -39.0621% | |
| -41.6454% | |
| -4.9619% | |
| 5.3631% | |
| 1.6913% | |
| 3.3839% | |
| -35.6896% | |
| -75.4744% | |
| -90.0671% | |
| -273.4683% | |
| -123.1589% | |
| -51.1179% | |
| -9.7785% | |
| 48.6271% | |
| 33.4996% | |
| 11.8285% | |
| -16.5139% | |
| -36.1941% | |
| -30.9464% | |
| 2.9792% | |
| 20.4002% | |
| 43.223% | |
| 54.1936% | |
| 53.0072% | |
| 59.0882% | |
| 48.4338% | |
| 35.1547% | |
| 24.9398% | |
| 11.4366% | |
| 1.8857% | |
| -18.5602% | |
| -45.2585% | |
| -95.237% | |
| -80.7048% | |
| -65.1733% |